Scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and combating fat accumulation, marking a significant leap in diabetes treatment innovation.

Kumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and ...

On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering ...

Purpose: The toxicology of oral antidiabetic agents is reviewed. Summary: Type 2 diabetes mellitus is increasing to near epidemic proportions, with a reported 190 million patients worldwide.

None of the currently approved antidiabetic agents has convincingly been proven to reduce this risk of CV disease, and some may actually increase the risk. As T2DM often requires life-long ...

Kumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and ...

Objective: To provide information on the use of oral antidiabetic agents in pregnancy and breast-feeding. Data Sources: Primary articles were identified by a MEDLINE search (1966-March 2007 ...

Kumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and combating fat ...